Literature DB >> 24969009

Patient-centeredness in the design of clinical trials.

C Daniel Mullins1, Joseph Vandigo2, Zhiyuan Zheng3, Paul Wicks4.   

Abstract

Evidence from clinical trials should contribute to informed decision making and a learning health care system. People frequently, however, find participating in clinical trials meaningless or disempowering. Moreover, people often do not incorporate trial results directly into their decision making. The lack of patient centeredness in clinical trials may be partially addressed through trial design. For example, Bayesian adaptive trials designed to adjust in a prespecified manner to changes in clinical practice could motivate people and their health care providers to view clinical trials as more applicable to real-world clinical decisions. The way in which clinical trials are designed can transform the evidence generation process to be more patient centered, providing people with an incentive to participate or continue participating in clinical trials. To achieve the transformation to patient-centeredness in clinical trial decisions, however, there is a need for transparent and reliable methods and education of trial investigators and site personnel.
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bayesian; adaptive; patient-centered; pragmatic; trial design

Mesh:

Year:  2014        PMID: 24969009      PMCID: PMC4497570          DOI: 10.1016/j.jval.2014.02.012

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  12 in total

1.  Continuous patient engagement in comparative effectiveness research.

Authors:  C Daniel Mullins; Abdulla M Abdulhalim; Danielle C Lavallee
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

2.  Adaptive trials receive boost.

Authors:  Dan Jones
Journal:  Nat Rev Drug Discov       Date:  2010-04-23       Impact factor: 84.694

3.  Clinical trials: the challenge of recruitment and retention of participants.

Authors:  Raisa B Gul; Parveen A Ali
Journal:  J Clin Nurs       Date:  2010-01       Impact factor: 3.036

Review 4.  A framework for applying unfamiliar trial designs in studies of rare diseases.

Authors:  Samir Gupta; Marie E Faughnan; George A Tomlinson; Ahmed M Bayoumi
Journal:  J Clin Epidemiol       Date:  2011-05-06       Impact factor: 6.437

Review 5.  What are pragmatic trials?

Authors:  M Roland; D J Torgerson
Journal:  BMJ       Date:  1998-01-24

6.  A 2020 vision of patient-centered primary care.

Authors:  Karen Davis; Stephen C Schoenbaum; Anne-Marie Audet
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

7.  Patient satisfaction with clinical trial participation.

Authors:  F W Verheggen; F H Nieman; E Reerink; G J Kok
Journal:  Int J Qual Health Care       Date:  1998-08       Impact factor: 2.038

Review 8.  Bayesian clinical trials.

Authors:  Donald A Berry
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

9.  Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments.

Authors:  Carlos Nakamura; Mark Bromberg; Shivani Bhargava; Paul Wicks; Qing Zeng-Treitler
Journal:  J Med Internet Res       Date:  2012-06-21       Impact factor: 5.428

Review 10.  Adaptive design methods in clinical trials - a review.

Authors:  Shein-Chung Chow; Mark Chang
Journal:  Orphanet J Rare Dis       Date:  2008-05-02       Impact factor: 4.123

View more
  28 in total

Review 1.  Secondary Use and Analysis of Big Data Collected for Patient Care.

Authors:  F J Martin-Sanchez; V Aguiar-Pulido; G H Lopez-Campos; N Peek; L Sacchi
Journal:  Yearb Med Inform       Date:  2017-09-11

Review 2.  How the EMERGE guideline on medication adherence can improve the quality of clinical trials.

Authors:  Lina Eliasson; Sarah Clifford; Amy Mulick; Christina Jackson; Bernard Vrijens
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

3.  Bridging the divide: building infrastructure to support community-academic partnerships and improve capacity to conduct patient-centered outcomes research.

Authors:  Jennifer Huang; Paula Darby Lipman; C Daniel Mullins
Journal:  Transl Behav Med       Date:  2017-12       Impact factor: 3.046

4.  Nephrologists' Perspectives on Defining and Applying Patient-Centered Outcomes in Hemodialysis.

Authors:  Allison Tong; Wolfgang C Winkelmayer; David C Wheeler; Wim van Biesen; Peter Tugwell; Braden Manns; Brenda Hemmelgarn; Tess Harris; Sally Crowe; Angela Ju; Emma O'Lone; Nicole Evangelidis; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-21       Impact factor: 8.237

5.  Missing data in primary care research: importance, implications and approaches.

Authors:  Miguel Marino; Jennifer Lucas; Emile Latour; John D Heintzman
Journal:  Fam Pract       Date:  2021-03-29       Impact factor: 2.267

6.  Design and analysis considerations for utilizing a mapping function in a small sample, sequential, multiple assignment, randomized trials with continuous outcomes.

Authors:  Holly Hartman; Roy N Tamura; Matthew J Schipper; Kelley M Kidwell
Journal:  Stat Med       Date:  2020-10-27       Impact factor: 2.497

7.  The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.

Authors:  Eugenia Oviedo-Joekes; Kirsten Marchand; Kurt Lock; Scott MacDonald; Daphne Guh; Martin T Schechter
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-01-26

Review 8.  Patient involvement in clinical research: why, when, and how.

Authors:  José A Sacristán; Alfonso Aguarón; Cristina Avendaño-Solá; Pilar Garrido; Juan Carrión; Alipio Gutiérrez; Robert Kroes; Angeles Flores
Journal:  Patient Prefer Adherence       Date:  2016-04-27       Impact factor: 2.711

9.  Why Most Clinical Research Is Not Useful.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2016-06-21       Impact factor: 11.069

10.  Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson's Disease.

Authors:  Heather L Benz; Brittany Caldwell; John P Ruiz; Anindita Saha; Martin Ho; Stephanie Christopher; Dawn Bardot; Margaret Sheehan; Anne Donnelly; Lauren McLaughlin; Brennan Mange; A Brett Hauber; Katrina Gwinn; William J Heetderks; Murray Sheldon
Journal:  MDM Policy Pract       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.